Search

everythinglearnresearchcommunity

for

Search:↓

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A dog developed a skin condition called pemphigus foliaceus after taking NexGard, but got better with treatment.

Peanut allergies can be transferred through organ transplants.

ILC1 cells contribute to hair loss in alopecia areata.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.